Ninety One North America’s Pfizer PFE Stock Holding History

Ninety One North America’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-65,317	Closed	-$2.71M	–	124
2018 Q4	$2.71M	Sell	65,317 -125,156	-66%	-$5.2M	0.29%	61
2018 Q3	$7.96M	Buy	190,473 +125,156	+192%	+$4.82M	0.68%	43
2018 Q2	$2.25M	Buy	65,317 +12,173	+23%	+$416K	0.16%	95
2018 Q1	$1.79M	Sell	53,144 -2,107	-4%	-$72.4K	0.14%	93
2017 Q4	$1.9M	Sell	55,251 -680	-1%	-$23.2K	0.3%	58
2017 Q3	$1.89M	Hold	55,931	–	–	0.32%	53
2017 Q2	$1.78M	Sell	55,931 -27,597	-33%	-$870K	0.33%	54
2017 Q1	$2.71M	Sell	83,528 -4,524	-5%	-$143K	0.51%	42
2016 Q4	$2.71M	Sell	88,052 -1,018	-1%	-$31.1K	0.41%	65
2016 Q3	$2.86M	Hold	89,070	–	–	0.38%	74
2016 Q2	$2.98M	Buy	89,070 +12,437	+16%	+$397K	0.44%	71
2016 Q1	$2.15M	Buy	76,633 +21,943	+40%	+$627K	0.36%	70
2015 Q4	$1.68M	Sell	54,690 -1,680	-3%	-$52.9K	0.3%	69
2015 Q3	$1.68M	Buy	56,370 +1,516	+3%	+$48.6K	0.42%	61
2015 Q2	$1.75M	Hold	54,854	–	–	0.56%	44
2015 Q1	$1.81M	Hold	54,854	–	–	0.56%	41
2014 Q4	$1.62M	Buy	+54,854	New	+$1.57M	0.48%	39

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ninety One North America's PFE Position: Q1 2019 in Review

Ninety One North America sold out of Pfizer (PFE) in Q1 2019, closing a stake of 65,317 shares — an estimated $2.71M sold.

Ninety One North America first reported a position in PFE in Q4 2014 and held it in 17 quarters. The position peaked at $7.96M in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

Ninety One North America reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
Ninety One North America sold 65,317 Pfizer shares in Q1 2019, an estimated $2.71M.
Ninety One North America first reported a position in Pfizer in Q4 2014 and held it in 17 quarters.
Ninety One North America's Pfizer position peaked at $7.96M in Q3 2018.
2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Ninety One North America's 13F filing for Q1 2019, filed 24 Apr 2019.